ACCESSION: MSBNK-SMB_Measured-HSA014P0243001
RECORD_TITLE: Annotated; Uridine; LC-ESI-QFT; MS2; NEGATIVE; generated fron DDA dataset
DATE: 2025.04.02 (Averaged 2025.02.21, Processed 2025.02.21, Annotated 2025.03.31, Curated 2025.04.02)
AUTHORS: Shin-MassBank project
LICENSE: CC BY-NC-SA
PUBLICATION: Ruggiero et al. Int J Cancer. 2023, 153, 1, 210-223
COMMENT: This is an averaged mass spectra data created by averaging product ion scan data obtained from the following DDA dataset.
COMMENT: The metabolite structure was annotated at Level 2a automatically. One of the possible structures is shown in the record.
COMMENT: REPOSITORY MetaboLights
COMMENT: DATASET_ID MTBLS6402
COMMENT: DATASET_TITLE FSCN1 as a new druggable target in adrenocortical carcinoma
COMMENT: DATASET_AUTHORS Andrei Turtoi, Enzo Lalli
COMMENT: MS1_M/Z_AVERAGED_THRES 5.000
COMMENT: MS2_M/Z_AVERAGED_THRES 5.000
COMMENT: DATASET_FILE_NUM 27
COMMENT: NUM_AVERAGED_SPEC 34
COMMENT: RAW_SPEC {'EL17-neg_1736': {'bp': 197569.0, 'sum': 606456.0}, 'EL14-neg_1738': {'bp': 192003.0, 'sum': 575724.0}, 'EL18-neg_1742': {'bp': 172012.0, 'sum': 544012.0}, 'EL02-neg_1756': {'bp': 170517.0, 'sum': 505936.0}, 'EL19-neg_1747': {'bp': 127753.0, 'sum': 382937.0}, 'EL13-neg_1746': {'bp': 116413.0, 'sum': 366228.0}, 'EL20-neg_1752': {'bp': 107859.0, 'sum': 333308.0}, 'EL02-neg_1723': {'bp': 107547.0, 'sum': 368060.0}, 'EL16-neg_1712': {'bp': 98584.0, 'sum': 318944.0}, 'EL15-neg_1721': {'bp': 91432.0, 'sum': 281682.0}, 'EL13-neg_1712': {'bp': 88400.0, 'sum': 297591.0}, 'EL18-neg_1709': {'bp': 83889.0, 'sum': 261592.0}, 'EL15-neg_1755': {'bp': 73958.0, 'sum': 245934.0}, 'EL17-neg_1703': {'bp': 69038.0, 'sum': 232584.0}, 'EL01-neg_1746': {'bp': 67535.0, 'sum': 222313.0}, 'EL03-neg_1718': {'bp': 63143.0, 'sum': 219798.0}, 'EL03-neg_1749': {'bp': 59790.0, 'sum': 200699.0}, 'EL01-neg_1714': {'bp': 58596.0, 'sum': 206760.0}, 'EL08-neg_1712': {'bp': 57804.0, 'sum': 192871.0}, 'EL16-neg_1746': {'bp': 56778.0, 'sum': 189984.0}, 'EL21-neg_1711': {'bp': 56367.0, 'sum': 185832.0}, 'EL06-neg_1747': {'bp': 56120.0, 'sum': 197744.0}, 'EL19-neg_1713': {'bp': 52938.0, 'sum': 193377.0}, 'EL06-neg_1715': {'bp': 48515.0, 'sum': 169566.0}, 'EL04-neg_1715': {'bp': 47068.0, 'sum': 152401.0}, 'EL14-neg_1705': {'bp': 46695.0, 'sum': 176076.0}, 'EL09-neg_1722': {'bp': 44233.0, 'sum': 141340.0}, 'EL20-neg_1719': {'bp': 42787.0, 'sum': 152863.0}, 'EL23-neg_1725': {'bp': 40966.0, 'sum': 141242.0}, 'EL24-neg_1713': {'bp': 38745.0, 'sum': 146275.0}, 'EL08-neg_1746': {'bp': 37924.0, 'sum': 135631.0}, 'EL21-neg_1746': {'bp': 35728.0, 'sum': 141161.0}, 'EL22-neg_1723': {'bp': 33728.0, 'sum': 138471.0}, 'EL05-neg_1725': {'bp': 32176.0, 'sum': 128000.0}}
COMMENT: RETENTION_TIME_STDEV 0.028
COMMENT: PRECURSOR_M/Z_RAW 243.062035
COMMENT: PRECURSOR_M/Z_STDEV 0.000095
COMMENT: PRECURSOR_IN_MS1 mz 243.062309; int 52.570; delta(ppm) 0.985755
COMMENT: PROPOSED_CHARGE_STATE -1; mz 244.065929; int 5.202; cor 0.956
COMMENT: PROPOSED_ISOTOPE_STATE ND
COMMENT: PROPOSED_ION_FORM M-H; M+Cl; mz 279.038889; int 6.451; cor 0.921
COMMENT: PROPOSED_ION_FORM M-H; M+FA-H; mz 289.067795; int 13.187; cor 0.959
COMMENT: PROPOSED_MAX_NUM_S 0
COMMENT: PROPOSED_MF SevenGoldenRules 0.217; C9H12N2O6; [M-H]1; delta(ppm) 0.217151
COMMENT: PROPOSED_MF MS-FINDER 3.897; C9H12N2O6; [M-H]-; delta(ppm) 0.219295
COMMENT: PROPOSED_MF MS-FINDER 2.635; C10H16N2OS2; [M-H]-; delta(ppm) -3.355981
COMMENT: PROPOSED_MF MS-FINDER 2.064; C11H17O2PS; [M-H]-; delta(ppm) 3.717767
COMMENT: PROPOSED_MF SIRIUS5_Sirius 29.658; C9H12N2O6; [M-H]-; delta(ppm) 0.219295
COMMENT: PROPOSED_MF SIRIUS5_Sirius 15.651; C10H8N6O2; [M-H]-; delta(ppm) -5.283028
COMMENT: PROPOSED_MF SIRIUS5_Sirius 8.032; C7H17O7P; [M-H]-; delta(ppm) -6.576313
COMMENT: PROPOSED_MF SIRIUS5_Sirius -0.745; C15H10F2O; [M-H]-; delta(ppm) -1.569591
COMMENT: PROPOSED_MF SIRIUS5_Sirius -0.823; C10H16N2OS2; [M-H]-; delta(ppm) -3.355981
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 1.000; C9H12N2O6; [M-H]-; delta(ppm) 0.219295
COMMENT: PROPOSED_MF SIRIUS6_Sirius 46.646; C9H12N2O6; [M-H]-; delta(ppm) 0.219295
COMMENT: PROPOSED_MF SIRIUS6_Sirius 29.572; C10H8N6O2; [M-H]-; delta(ppm) -5.283028
COMMENT: PROPOSED_MF SIRIUS6_Sirius 28.556; C7H10N5O5; [M-H]-; delta(ppm) 5.743276
COMMENT: PROPOSED_MF SIRIUS6_Sirius 28.401; C8H16N2O3Si2; [M-H]-; delta(ppm) -208283.653821
COMMENT: PROPOSED_MF SIRIUS6_Sirius 27.986; C7H17O7P; [M-H]-; delta(ppm) -6.576313
COMMENT: PROPOSED_MF SIRIUS6_Sirius 26.015; C5H15N3O6P; [M-H]-; delta(ppm) -1.052407
COMMENT: PROPOSED_MF SIRIUS6_Sirius 25.955; C9H10BF2NO4; [M-H]-; delta(ppm) 42959.788053
COMMENT: PROPOSED_MF SIRIUS6_Sirius 25.627; C6H13FN2O7; [M-H]-; delta(ppm) -4.481759
COMMENT: PROPOSED_MF SIRIUS6_Sirius 25.523; C8H17ClO6; [M-H]-; delta(ppm) -89872.722524
COMMENT: PROPOSED_MF SIRIUS6_Sirius 22.771; C7H14F2N2O3S; [M-H]-; delta(ppm) 1.111257
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C9H12N2O6; [M-H]-; delta(ppm) 0.219295
COMMENT: PROPOSED_COMPOUND SIMILARITY:GNPS 14.000; DRTQHJPVMGBUCF-XVFCMESISA-N; C9H12N2O6; Uridine - 40.0 eV
COMMENT: PROPOSED_COMPOUND SIMILARITY:GNPS 7.000; DRTQHJPVMGBUCF-UHFFFAOYSA-N; C9H12N2O6; uridine CollisionEnergy:205060
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.737; WGDUUQDYDIIBKT-NHBCCFCANA-N; [M-H]-; O[C@@H]1O[C@H](CN2C=CC(=O)NC2=O)[C@@H](O)[C@H]1O
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.721; DRTQHJPVMGBUCF-NHBCCFCANA-N; [M-H]-; OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=CC(=O)NC1=O
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.671; ZXFPQLYUODNTFK-FPRPZMINNA-N; [M-H]-; O[C@@H]1CO[C@@H]([C@@H](O)[C@@H]1O)C1=CNC(=O)NC1=O
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.615; CYFJUPFBCYRZFA-CCXZUQQUSA-N; [M-H]-; C1C(C(C(C(O1)N2C=CC(=O)NC2=O)O)O)O
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.546; PTJWIQPHWPFNBW-XZLSUNLFNA-N; [M-H]-; OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)C1=CNC(=O)NC1=O
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.659; DRTQHJPVMGBUCF-NHBCCFCANA-N; [M-H]-; Uridine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.387; PTJWIQPHWPFNBW-XZLSUNLFNA-N; [M-H]-; Pseudouridine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.841; LQDZJEZNUDFDNE-WHFBIAKZSA-N; [M-H]-; UNPD230148
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.821; UMTHIZRIDGLMBU-BIGNFAASNA-N; [M-H]-; UNPD120250
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.785; WGDUUQDYDIIBKT-NHBCCFCANA-N; [M-H]-; UNPD168314
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.773; NBNBAENCKIJZAH-NHBCCFCANA-N; [M-H]-; UNPD148852
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.739; ZXFPQLYUODNTFK-FPRPZMINNA-N; [M-H]-; UNPD177803
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.725; CYFJUPFBCYRZFA-CCXZUQQUSA-N; [M-H]-; 1-[(2R,3S,4R,5R)-3,4,5-trihydroxyoxan-2-yl]pyrimidine-2,4-dione
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.720; BGSCNPOVJFBBAQ-WCTZXXKLSA-N; [M-H]-; 1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxypyrimidin-2-one
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.561; JEHQSGHHQIZUCW-UHFFFAOYSA-N; [M-H]-; 5,5-dipropyl-2,6-disulfanylidene-1,3-diazinan-4-one
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; WGDUUQDYDIIBKT-NHBCCFCANA-N; [M-H]-; UNPD168314
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.976; LQDZJEZNUDFDNE-WHFBIAKZSA-N; [M-H]-; UNPD230148
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.878; PTJWIQPHWPFNBW-XZLSUNLFNA-N; [M-H]-; Pseudouridine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.872; ZXFPQLYUODNTFK-FPRPZMINNA-N; [M-H]-; UNPD177803
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.730; DRTQHJPVMGBUCF-NHBCCFCANA-N; [M-H]-; Uridine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.718; CYFJUPFBCYRZFA-CCXZUQQUSA-N; [M-H]-; 1-[(2R,3S,4R,5R)-3,4,5-trihydroxyoxan-2-yl]pyrimidine-2,4-dione
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.650; NBNBAENCKIJZAH-NHBCCFCANA-N; [M-H]-; UNPD148852
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.582; BGSCNPOVJFBBAQ-WCTZXXKLSA-N; [M-H]-; 1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxypyrimidin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.575; UMTHIZRIDGLMBU-BIGNFAASNA-N; [M-H]-; UNPD120250
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 3.831; DRTQHJPVMGBUCF-XVFCMESISA-N; [M-H]-; 1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidine-2,4-dione
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.985; PTJWIQPHWPFNBW-GBNDHIKLSA-N; [M-H]-; 5-[(2S,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1H-pyrimidine-2,4-dione
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -1.952; DRTQHJPVMGBUCF; [M-H]-; b-Uridine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -74.798; NBNBAENCKIJZAH; [M-H]-; 3-pentofuranosylpyrimidine-2,4(1h,3h)-dione
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -151.600; WGDUUQDYDIIBKT; [M-H]-; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -156.470; UIJSURSVLVISBO; [M-H]-; 2''-deoxy-5-hydroxyuridine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -249.965; PTJWIQPHWPFNBW; [M-H]-; y-Uridine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -261.045; UMTHIZRIDGLMBU; [M-H]-; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -274.308; RXZPAINEZWIFJD; [M-H]-; 1-pentofuranosylpyrazin-2(1H)-one 4-oxide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -287.950; PZGDFRVEIQKOKB; [M-H]-; 3-Deaza-6-azauridine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -340.827; ZXFPQLYUODNTFK; [M-H]-; Uracil, 5-xylopyranosyl-
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -414.348; LQDZJEZNUDFDNE; [M-H]-; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -486.518; YSRISZVOJDAOFB; [M-H]-; Oxazofurin
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -495.847; RYZHANTZYYFSGC; [M-H]-; (5R,6R,7S,8S)-6,7,8-trihydroxy-5-(hydroxymethyl)-5,6,7,8-tetrahydroimidazo[1,2-a]pyridine-2-carboxylic acid
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -525.346; OKLRJJIBPYTEDZ; [M-H]-; 3-[3-(carboxymethoxy)-5-methyl-1,2-oxazol-4-yl]alanine
COMMENT: PROPOSED_COMPOUND SIRIUS5_Confidence:biodatabase 0.643; DRTQHJPVMGBUCF; [M-H]-; b-Uridine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -12.670; DRTQHJPVMGBUCF; [M-H]-; Uridin
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -88.476; NBNBAENCKIJZAH; [M-H]-; 3-[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,2,3,4-tetrahydropyrimidine-2,4-dione
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -141.432; CYFJUPFBCYRZFA; [M-H]-; 1-[(2R,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]pyrimidine-2,4-dione
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -154.622; RXZPAINEZWIFJD; [M-H]-; 1-[3,4-Dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-4-oxidopyrazin-4-ium-2-one
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -160.111; UMTHIZRIDGLMBU; [M-H]-; 1-[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-2-oxo-2,3-dihydro-1H-imidazole-4-carbaldehyde
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -161.784; UIJSURSVLVISBO; [M-H]-; 5-Hydroxy-2'-deoxyuridine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -168.139; WGDUUQDYDIIBKT; [M-H]-; 1-[(3,4,5-trihydroxyoxolan-2-yl)methyl]-1,2,3,4-tetrahydropyrimidine-2,4-dione
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -177.782; PTJWIQPHWPFNBW; [M-H]-; Psi-Uridine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -206.441; PZGDFRVEIQKOKB; [M-H]-; 3-Deaza-6-azauridine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -241.555; ZXFPQLYUODNTFK; [M-H]-; 5-(3,4,5-trihydroxyoxan-2-yl)-1,2,3,4-tetrahydropyrimidine-2,4-dione
COMMENT: PROPOSED_COMPOUND SIRIUS6_Confidence:biodatabase 0.888; DRTQHJPVMGBUCF; [M-H]-; Uridin
COMMENT: CONFIDENCE Level 2a: Probable structure by library spectrum match Uridine, DRTQHJPVMGBUCF-XVFCMESISA-N; Matching to 14 measured spectra (Dot product > 0.7); Proposed by SIRIUS6_Confidence with FDR < 0.1; Supported by other software with ranking <= 10 MetFrag:PubchemLite (1); This structural isomer was suggested from the biological context HMDB HMDB0000296;
CH$COMPOUND_CLASS: Natural product
CH$FORMULA: C9H12N2O6
CH$EXACT_MASS: 244.069536
CH$SMILES: C1=CN(C(=O)NC1=O)[C@H]2[C@@H]([C@@H]([C@H](O2)CO)O)O
CH$IUPAC: InChI=1S/C9H12N2O6/c12-3-4-6(14)7(15)8(17-4)11-2-1-5(13)10-9(11)16/h1-2,4,6-8,12,14-15H,3H2,(H,10,13,16)/t4-,6-,7-,8-/m1/s1
CH$NAME: Uridine
CH$NAME: Uridine
CH$NAME: 1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidine-2,4-dione
CH$LINK: INCHIKEY DRTQHJPVMGBUCF-XVFCMESISA-N
CH$LINK: PUBCHEM CID:6029
SP$SCIENTIFIC_NAME: Homo sapiens
SP$LINK: NCBI-TAXONOMY 9606 
SP$SAMPLE: Cell
AC$INSTRUMENT: Vanquish Flex UHPLC system, Thermo Fisher Scientific - Orbitrap Q Exactive Plus mass spectrometer, Thermo Fisher Scientific
AC$INSTRUMENT_TYPE: LC-ESI-QFT
AC$MASS_SPECTROMETRY: MS_TYPE MS2
AC$MASS_SPECTROMETRY: ION_MODE NEGATIVE
AC$MASS_SPECTROMETRY: COLLISION_ENERGY Ramped collision energies of 40 V
AC$MASS_SPECTROMETRY: FRAGMENTATION_MODE CID
AC$MASS_SPECTROMETRY: ION_SPRAY_VOLTAGE 4.0 kV
AC$MASS_SPECTROMETRY: IONIZATION ESI
AC$MASS_SPECTROMETRY: MASS_ACCURACY MS1(ppm) 5.00; MS2(ppm) 5.00
AC$CHROMATOGRAPHY: COLUMN_NAME ZORBAX Pursuit 3 PFP (3 µm, 2.0 mm x 150 mm; Agilent Technologies)
AC$CHROMATOGRAPHY: FLOW_GRADIENT The gradient profile was linear decrease from 0-25% B from 0-2 min; fast linear increase from 25-35% B from 2-11 min; 95% B hold from 15-20 min;fast linear decrease from 95-0% B from 20-21 min. 
AC$CHROMATOGRAPHY: RETENTION_TIME 2.950
MS$FOCUSED_ION: ION_TYPE [M-H]-
MS$FOCUSED_ION: PRECURSOR_M/Z 243.062313
MS$DATA_PROCESSING: RECALIBRATE Data dependent recalibration using whole DDA dataset
PK$SPLASH: splash10-0ik9-3940000000-063dda8513bb5c22eb4f
PK$ANNOTATION: m/z int m/z_nocal m/z_std(ppm) int_std cor n annotation
  66.0335212 146.2335 66.033500 0.9086 25.41 0.9110 33 ?
  82.0284140 299.4848 82.028405 0.8290 34.07 0.9125 34 ?
  99.9243874 81.8450 99.924400 1.2610 45.03 0.0695 32 ?
  110.0233714 999.0000 110.023400 0.5181 0.00 0.9552 34 ?
  111.0187668 62.5645 111.018797 1.0899 14.70 0.8968 28 ?
  122.0234890 85.2301 122.023540 1.1719 18.06 0.8839 33 ?
  140.0341381 101.6218 140.034230 1.1711 17.87 0.9074 31 f{C6H6N1O3}/-8.42ppm,p-C3H5N1O3
  152.0341651 178.1406 152.034289 1.2695 18.75 0.9190 30 f{C7H6N1O3}/-7.57ppm,p-C2H5N1O3
  200.0564409 338.0892 200.055910 0.8798 28.51 0.9435 34 f{C8H10N1O5}/-0.03ppm,p-C1H1N1O1
  242.1760563 148.8404 242.176010 1.5443 82.79 -0.2129 31 ?
  243.0623539 237.1185 243.062320 1.2425 33.44 1.0000 31 f{C9H11N2O6}/0.39ppm,p
PK$NUM_PEAK: 11
PK$PEAK: m/z int. rel.int.
  66.033521 146.23 146
  82.028414 299.48 299
  99.924387 81.84 81
  110.023371 999.00 999
  111.018767 62.56 62
  122.023489 85.23 85
  140.034138 101.62 101
  152.034165 178.14 178
  200.056441 338.09 338
  242.176056 148.84 148
  243.062354 237.12 237
//
